Which has the lower trailing P/E, BIO or ENSG?

ENSG has the lower trailing P/E: BIO trades at 47.11 and ENSG at 27.20. P/E is one valuation measure and does not by itself establish which business is cheaper.

Which has grown faster, BIO or ENSG?

Over the past five years, ENSG grew revenue faster — BIO at a 0.29% CAGR versus ENSG at 17.08%.

Does BIO or ENSG pay a bigger dividend?

ENSG pays a dividend (0.15% yield), while BIO has no payments in the available dividend history.

Is BIO or ENSG more profitable?

BIO runs the higher net margin — BIO at 8.59% versus ENSG at 6.90%.

How have BIO and ENSG total returns compared?

Over the past 10 years, BIO delivered 9.90% and ENSG delivered 26.44% annualized total return. Past performance doesn't predict future results.

Bio-Rad Laboratories, Inc. (BIO) vs The Ensign Group, Inc. (ENSG)

A side-by-side comparison of Bio-Rad Laboratories, Inc. and The Ensign Group, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of August 27, 2026. Differences are shown without an overall score or investment verdict.

BIO

Bio-Rad Laboratories, Inc.

$10.50B

$389.94HealthcareDelayed quote: Aug 27, 2026, 4:00 PM EDT

ENSG

The Ensign Group, Inc.

$10.11B

$173.54HealthcareDelayed quote: Aug 27, 2026, 4:00 PM EDT

Total return — BIO vs ENSG

growth of $100 · dividends reinvested · last 10y

BIO +158.0% (+9.9%/yr)ENSG +966.7% (+26.7%/yr)ENSG compounded faster over this window

BIO ENSG

BIO vs ENSG: by the numbers

•BIO is the larger company ($10.50B vs $10.11B market cap).
•ENSG trades at the lower trailing earnings multiple (27.20 vs 47.11 P/E), one valuation lens rather than an overall verdict.
•BIO converts more revenue to profit (8.59% vs 6.90% net margin).
•ENSG grew revenue faster over the past five years (17.08% vs 0.29% CAGR).
•ENSG pays a dividend (0.15% yield), while BIO has no payments in the available dividend history.

Metrics side by side

Valuation

Metric	BIO	ENSG
P/E ratio	47.11	27.20
Forward P/E	40.31	22.26
P/S ratio	4.02	1.88
P/B ratio	1.45	4.23
EV / EBITDA	29.04	21.15
FCF yield	3.39%	4.06%

Profitability

Metric	BIO	ENSG
Gross margin	51.90%	14.14%
Operating margin	9.08%	8.52%
Net margin	8.59%	6.90%
ROE	3.10%	15.51%
ROIC	1.54%	7.29%

Dividends

Metric	BIO	ENSG
Dividend yield	N/A	0.15%
Payout ratio	N/A	4.29%

Growth (annualized)

Metric	BIO	ENSG
Revenue CAGR (5Y)	0.29%	17.08%
EPS CAGR (5Y)	-26.27%	13.47%
FCF CAGR (5Y)	-9.65%	10.84%
Total return CAGR (5Y)	-13.40%	16.34%

Frequently asked

Which has the lower trailing P/E, BIO or ENSG?: ENSG has the lower trailing P/E: BIO trades at 47.11 and ENSG at 27.20. P/E is one valuation measure and does not by itself establish which business is cheaper.
Which has grown faster, BIO or ENSG?: Over the past five years, ENSG grew revenue faster — BIO at a 0.29% CAGR versus ENSG at 17.08%.
Does BIO or ENSG pay a bigger dividend?: ENSG pays a dividend (0.15% yield), while BIO has no payments in the available dividend history.
Is BIO or ENSG more profitable?: BIO runs the higher net margin — BIO at 8.59% versus ENSG at 6.90%.
How have BIO and ENSG total returns compared?: Over the past 10 years, BIO delivered 9.90% and ENSG delivered 26.44% annualized total return. Past performance doesn't predict future results.

Go deeper

Full BIO analysis Full ENSG analysis Interactive comparison tool

Dig into the metrics

Bio-Rad Laboratories P/E ratio Ensign P/E ratio Ensign dividend yield Bio-Rad Laboratories ROE Ensign ROE Bio-Rad Laboratories operating margin Ensign operating margin Bio-Rad Laboratories revenue growth Ensign revenue growth Bio-Rad Laboratories free cash flow Ensign free cash flow

Bio-Rad Laboratories & Ensign appear in these rankings

Fastest Revenue Growth Stocks Highest FCF Yield Stocks Highest 10-Year Total Return Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified August 27, 2026.